Stocks · Health care · Services-Commercial Physical & Biological Research

Medpace Holdings, Inc.

MEDP Clue Score73
United States Fiscal year ends December CIK 0001668397 Results filed 21 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Susan E Burwig
26 Oct 2026
Exec. VP, Operations
Sold after exercise
16,060
$677.00
$10.87M
Robert O. Kraft
26 Aug 2026
Director
Sold after exercise
3,858
$617.81
$2.38M
Kevin M. Brady
20 Aug 2026
CFO & Treasurer
Sold after exercise
3,400
$625.24
$2.13M
Fred B Davenport Jr
19 Aug 2026
Director
Sold after exercise
7,283
$606.15
$4.41M
Cornelius P. McCarthy III
7 Aug 2026
Director
Sold after exercise
795
$585.07
$465.13K
Stephen P Ewald
28 May 2026
General Counsel & Corp. Secy.
Sold after exercise
16,349
$450.00
$7.36M
Jesse J Geiger
17 Mar 2026
President
Sold after exercise
31,707
$455.30
$14.44M
Kevin M. Brady
21 Nov 2025
CFO & Treasurer
Sold after exercise
3,000
$590.35
$1.77M
Robert O. Kraft
14 Nov 2025
Director
Sold after exercise
6,472
$591.85
$3.83M

What was left out

Form 4 filings counted 72
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 9
Sales at will 46
Transactions with no price 0
Shares from compensation/vesting 151,339
History held since 12 Aug 2016